Bone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationHematopoietic Stem CellsGraft vs Host DiseaseTransplantation ConditioningTransplantation, AutologousStem CellsBone MarrowTransplantation ChimeraBone Marrow CellsHematologic NeoplasmsPeripheral Blood Stem Cell TransplantationTissue DonorsLiver TransplantationGraft SurvivalBusulfanWhole-Body IrradiationTreatment OutcomeLeukemiaHistocompatibility TestingRecurrenceGraft vs Leukemia EffectRemission InductionImmunosuppressive AgentsHistocompatibilityMyeloablative AgonistsKidney TransplantationGraft vs Tumor EffectAnemia, AplasticLeukemia, Myeloid, AcuteHematopoiesisLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCombined Modality TherapyCord Blood Stem Cell TransplantationLymphocyte TransfusionRetrospective StudiesVidarabineHematopoietic Stem Cell MobilizationCyclophosphamideTime FactorsAntigens, CD34Lymphocyte DepletionMyelodysplastic SyndromesSurvival AnalysisPrecursor Cell Lymphoblastic Leukemia-LymphomaMultiple MyelomaCell DifferentiationCytomegalovirus InfectionsTransplantation, IsogeneicHepatic Veno-Occlusive DiseaseTransplantation ImmunologyMice, Inbred C57BLSurvival RateDisease-Free SurvivalMesenchymal Stem Cell TransplantationChimerismT-LymphocytesGraft RejectionHeart TransplantationAcute DiseaseAntilymphocyte SerumSiblingsCell TransplantationMinor Histocompatibility AntigensEmbryonic Stem CellsSalvage TherapyHLA AntigensMelphalanImmunosuppressionHematologic DiseasesBone and BonesAdult Stem CellsLung TransplantationFlow CytometryAntineoplastic Combined Chemotherapy ProtocolsLeukemia, MyeloidNeoplasm, ResidualCell LineageFollow-Up StudiesBone Marrow PurgingColony-Forming Units AssayStem Cell NicheGranulocyte Colony-Stimulating FactorCells, CulturedOrgan TransplantationLymphoma, Non-HodgkinVirus ActivationRadiation ChimeraPrognosisLeukocyte TransfusionCytarabineCyclosporineCytomegalovirusPrimary MyelofibrosisNuclear FamilyCell SeparationImmunocompromised HostMesenchymal Stromal Cells